Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- fever, chills, malaise
- tender prostate
Outros fatores diagnósticos
- age <50 years
- urinary frequency
- dysuria
- diminished urinary stream
- perineal pain
- warm or soft, boggy gland
- indwelling urinary catheter
- recent transrectal prostate biopsy
- recent transurethral surgery
Fatores de risco
- urinary tract infection (UTI)
- benign prostatic enlargement
- urinary tract instrumentation/manipulation
- poor general health/immunosuppression
- smoking and alcohol consumption
- genetics
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- urinalysis
- urine culture
- blood cultures
Tests to avoid
- prostatic biopsy
- serum prostate-specific antigen (PSA)
Investigações a serem consideradas
- transrectal ultrasound
- 4-glass or 2-glass test
Algoritmo de tratamento
signs of sepsis
without signs of sepsis
Colaboradores
Autores
Christopher Chapple, BSc, MD, FRCS (Urol), FEBU
Honorary Senior Lecturer of Urology
University of Sheffield
Consultant Urological Surgeon
Department of Urology
Royal Hallamshire Hospital
Sheffield
UK
Declarações
CC is a consultant for Astellas, Contura, Ferring, Symimetic, Takeda, and Urovant Sciences. He is an author for Astellas and Ferring. He is an investigator for Allergan, Astellas, Ferring, Poesis Medical, and Bayer. He is a co-patent holder for Symimetic. He is a speaker for Allergan and Astellas.
Altaf Mangera, MBChB (Hons), MD, FRCS (Urol)
Consultant Urologist
Department of Urology
Royal Hallamshire Hospital
Sheffield
UK
Declarações
AM declares that he has no competing interests.
Agradecimentos
Dr Christopher Chapple and Dr Altaf Mangera would like to gratefully acknowledge the contribution of Robyn Webber MB, ChB, MD, FRCSEd (Urol) to this topic. Not disclosed.
Revisores
Hans Hedelin, MD
Department of Urology and Centre for Research and Development
Karnsjukhuset
Skovde
Sweden
Declarações
HH declares that he has no competing interests.
Benjamin A. Lipsky, MD, FACP, FIDSA, FRCP
Professor of Medicine
University of Washington
VA Puget Sound Health Care System
Seattle
WA
Declarações
BAL has received research funding from, and been a consultant to, several pharmaceutical companies that make antibiotic agents that might be used for treating bacterial prostatitis.
Referências
Principais artigos
Rothman JR, Jaffe WI. Prostatitis: updates on diagnostic evaluation. Curr Urol Rep. 2007 Jul;8(4):301-6. Resumo
Krieger JN, Lee SW, Jeon J, et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008 Feb;31(suppl 1):S85-90.Texto completo Resumo
European Association of Urology. Guidelines on urological infections. 2022 [internet publication].Texto completo
Nickel JC. Prostatitis. Can Urol Assoc J. 2011 Oct;5(5):306-15.Texto completo Resumo
National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. Oct 2018 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Benign prostatic hyperplasia (BPH)
- Prostate cancer
- Urinary tract infection (UTI)
Mais Diagnósticos diferenciaisDiretrizes
- Urological infections
- Acute bacterial prostatitis: diagnosis and management
Mais DiretrizesFolhetos informativos para os pacientes
Prostatitis
Mais Folhetos informativos para os pacientes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal